Agilent Technologies Inc. has launched new SureScan Dx microarray scanner that is CE marked for in vitro diagnostic use in Europe. The SureScan Dx microarray scanner is indicated for use in a clinical ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification ...
Agilent Technologies Inc. announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback